2023 annual financial data
Vistagen Therapeutics 2023 Operating margin
Vistagen Therapeutics 2023 operating margin with verified reported values.
Direct answer
Operating margin was 26,074.79%.
Operating income was -59,268,000 USD and net income was -59,247,700 USD.
Operating cash flow was -49,715,100 USD.
Get free Vistagen Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- -227,300 USD
- Operating income
- -59,268,000 USD
- Net income
- -59,247,700 USD
- Operating cash flow
- -49,715,100 USD